login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
VALEANT PHARMACEUTICALS INTL I (VRX) Stock News
USA
-
New York Stock Exchange
- NYSE:VRX -
CA91911K1021
23.4
-0.83 (-3.43%)
Last: 7/13/2018, 8:04:05 PM
23.36
-0.04 (-0.17%)
After Hours:
7/13/2018, 8:04:05 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
VRX Latest News, Press Relases and Analysis
All
Press Releases
7 years ago - By: Barron's
- Mentions:
XPH
XLV
Valeant: It’s More Than Just Dermatology
6 years ago - By: InvestorPlace
- Mentions:
TEVA
CHK
GWPH
CSIQ
...
9 High-Risk Stocks to Buy for Massive Rewards
6 years ago - By: Bausch Health Companies Inc.
- Mentions:
BHC
Bausch Health Companies Inc. Will Release Second-Quarter 2019 Financial Results On August 6
7 years ago - By: InvestorPlace
- Mentions:
TEVA
CHK
GWPH
CSIQ
...
9 High-Risk Stocks to Buy for Massive Rewards
7 years ago - By: Benzinga
- Mentions:
XBI
BIIB
CELG
IBB
...
6 Valuable Pipeline Drugs With Upcoming Catalysts
7 years ago - By: Analyst Ratings
H.C. Wainwright Upgrades Valeant Pharm International (VRX) to Buy
7 years ago - By: Bausch Health Companies Inc.
- Mentions:
BHC
Bausch + Lomb Receives 510(K) Clearance From FDA For Bausch + Lomb Ultra® Multifocal For Astigmatism Contact Lenses
7 years ago - By: InvestorPlace
- Mentions:
TEVA
CHK
GWPH
CSIQ
...
9 High-Risk Stocks to Buy for Massive Rewards
7 years ago - By: Analyst Ratings
Valeant Pharm International (VRX) Gets a Buy Rating from Cantor Fitzgerald
7 years ago - By: Bausch Health Companies Inc.
- Mentions:
BHC
Bausch Health Launches ALTRENO™ (tretinoin) Lotion, 0.05% In The United States
7 years ago - By: Bausch Health Companies Inc.
- Mentions:
BHC
Bausch Health Announces Publication Of Pivotal Phase 3 Efficacy And Safety Data On ALTRENO™ (tretinoin) Lotion, 0.05% In The Journal Of Drugs In Dermatology
7 years ago - By: InvestorPlace
- Mentions:
PYX
CGC
STZ
NBEV
...
Pyxus Stock Could Backfire Over the Longer Term
7 years ago - By: InvestorPlace
- Mentions:
CRON
STZ
CGC
TLRY
...
There’s Just No Reason to Rush Into Cronos Stock
7 years ago - By: InvestorPlace
- Mentions:
TEVA
CHK
GWPH
CSIQ
...
9 High-Risk Stocks to Buy for Massive Rewards
7 years ago - By: The Motley Fool
- Mentions:
BHC
Why Bausch Health Companies Stock Has Gained Nearly 12% Halfway Through 2018
7 years ago - By: MarketNewsUpdates.com
- Mentions:
STAA
EYEG
AGN
International Ophthalmology and Optometry Devices Market Booming With New Growth Opportunities
7 years ago - By: Benzinga
- Mentions:
ALNY
DRRX
FOLD
IBB
...
Attention Biotech Investors: Mark Your Calendar For These August PDUFA Dates
7 years ago - By: Smarter Analyst
Mizuho Sets Expectations on Valeant (VRX) Ahead of Earnings
7 years ago - By: InvestorPlace
- Mentions:
CELG
GILD
PFE
BIIB
...
3 Real Risks That Could Make You Reconsider Buying Celgene Stock
7 years ago - By: TalkMarkets
- Mentions:
OIL
NDX
SPX
NYA
...
2,800 Tuesday and the S&P – Are We There Yet?
7 years ago - By: Bausch + Lomb
Bausch + Lomb Announces U.S. FDA Filing Acceptance For Loteprednol Etabonate Ophthalmic Gel, 0.38%
7 years ago - By: InvestorPlace
- Mentions:
TEVA
AGN
SNY
PFE
...
5 Pharmaceutical and Biotech Stocks to Consider for July
7 years ago - By: MarketWatch
- Mentions:
SPX
DJIA
Valeant is back on to its old drug-pricing ways
7 years ago - By: TalkMarkets
- Mentions:
SYN
Mizuho Says Synthetic Biologics IBS Treatment May Be 'Interesting' For Valeant
Please enable JavaScript to continue using this application.